ηcv

CV-6209 是一种具有选择性和高效性的血小板活化因子 (PAF) 拮抗剂，具有抗增殖作用，部分抑制乙酰胆碱诱导的低血压，抑制 Paf 诱导的 PMN 或血小板聚集。CV-6209 具有抗幽门螺杆菌作用，可以抑制 PAF 引起的大鼠低血压。

CV 5975 is a nonsulfhydryl ACE inhibitor that was investigated for use in hypertension and heart failure.

CV-1674 induced selective coronary vasodilation and had little effect on cardiac hemodynamics.

CV 6504 is a dual inhibitor of thromboxane A2 synthetase and 5-lipoxygenase. It also possesses oxygen scavenging activity.

CV 11464 is a bioactive chemical.

CV-159 is a unique dihydropyridine Ca2+ antagonist with antiinflammatory activities. It has an anti-calmodulin (CaM) action.

CV-3988 is a specific antagonist of PAF-R (platelet-activating factor receptor)(Ki = 0.872 μM).

CV 4388 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T68029，CAS号为 93943-87-4。

CV-1808 is a coronary vasodilator, antihypertensive, and antipsychotic following systemic administration in vivo. CV-1808 is an adenosine A2 receptor agonist.

CV122, 一种肝素酶 (heparanase) 抑制剂，具有 2.97 µM 的 IC50 值，能有效抑制促炎细胞因子，适用于败血症的研究。

HCV-IN-29 是一种丙型肝炎病毒抑制剂。